Filter By:

Choose an area from the filter to limit results to that area and show available options for further filtering

Funding Awarded

6 awards

  • Irish Platform for Patients Organisations Science and Industry Support Award remove from filter
  • Irish Platform for Patients Organisations Science and Industry

    The Irish Platform for Patients' Organisations, Science and Industry (IPPOSI) is a unique organisation in Ireland and abroad. The platform brings together patient groups, scientists, clinicians, industry and other key decision makers to discuss and build consensus on issues relevant to all involved in delivering treatments to people...

  • Prevention of postoperative persistent bowel symptoms in patients with Hirschsprung's Disease

    Hirschsprung's disease (HD) is a relatively common cause of intestinal obstruction in the new-born, occurring in 1 in 4,000 live births. It is characterised by abnormal development of the nerve supply to varying lengths of the large bowel prior to birth. The gold standard treatment for HD is an operation to remove the diseased bowel...

  • Irish Platform for Patients Organisations Science and Industry

    The Irish Platform for Patients' Organisations, Science and Industry (IPPOSI) is a unique organisation in Ireland and abroad. The platform brings together patient groups, scientists, clinicians, industry and other key decision makers to discuss and build consensus on issues relevant to all involved in delivering treatments to people...

  • Genetic basis of reflux nephropathy-related hypertension and renal failure in children

    Vesicoureteric reflux (VUR) is the backflow of urine from the bladder towards the kidneys. It is a common disorder in children, but is often not diagnosed because it may have no symptoms. In some children, it stops happening as they grow, and they suffer no ill effects. However, it can be associated with kidney damage, and is a major...

  • Irish Platform for Patients Organisations Science and Industry

    The purpose of this award is to enable IPPOSI to undertake a work programme providing a forum for patient organisations, scientists and industry to inform and support the advancement of health research for the development of therapies and cures for unmet medical needs specifically but not limited to:

    • Providing information...

    • Irish Platform for Patients Organisations Science and Industry

      IPPOSI brings together patient groups, scientists, clinicians, industry and other key decision makers to discuss and build consensus on issues relevant to delivering treatments to people with unmet medical needs. On behalf of the DOH, the HRB has been co-funding IPPOSI with between 40-50% of their annual income since 2007. The...